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Abstract
Targeted deletion of S6 kinase (S6K) 1 in mice leads to higher energy expenditure and improved glucose metabolism.
However, the molecular mechanisms controlling these effects remain to be fully elucidated. Here, we analyze the potential
role of dietary lipids in regulating the mTORC1/S6K system. Analysis of S6K phosphorylation in vivo and in vitro showed that
dietary lipids activate S6K, and this effect is not dependent upon amino acids. Comparison of male mice lacking S6K1 and 2
(S6K-dko) with wt controls showed that S6K-dko mice are protected against obesity and glucose intolerance induced by a
high-fat diet. S6K-dko mice fed a high-fat diet had increased energy expenditure, improved glucose tolerance, lower fat
mass gain, and changes in markers of lipid metabolism. Importantly, however, these metabolic phenotypes were dependent
upon dietary lipids, with no such effects observed in S6K-dko mice fed a fat-free diet. These changes appear to be mediated
via modulation of cellular metabolism in skeletal muscle, as shown by the expression of genes involved in energy
metabolism. Taken together, our results suggest that the metabolic functions of S6K in vivo play a key role as a molecular
interface connecting dietary lipids to the endogenous control of energy metabolism.
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Introduction
Control of energy balance plays a central role in diseases such as
obesity and metabolic syndrome, where pharmacological suppres-
sion of appetite alone appears to be insufficient to prevent or reverse
weight gain and adiposity. In order to control the balance between
food intake (FI) and energy expenditure (EE), however, further
insights will be required into the molecular pathways that control
key processes such as nutrient sensing and energy metabolism, and
in particular the regulatory mechanisms that integrate them.
S6 kinases (S6K) 1 and 2 are key effectors of the mammalian
target of rapamycin complex 1 (mTORC1) and are well known to
play a positive anabolic role in insulin-mediated cell growth and to
suppress insulin signaling under conditions of hyperactivation of
the mTORC1 pathway [1]. The mTORC1/S6K pathway has
also been implicated in nutrient sensing, however. Glucose and
leucine are known to function as key dietary components involved
in activating S6K [2,3], and dietary fatty acids are also known to
activate S6K in liver and muscle [4] and in the hypothalamus [5]
of rats fed on a high-fat diet (HFD).
Apart from a potential role in nutrient sensing, S6K1 has also
been reported to control systemic energy homeostasis. We have
previously demonstrated that global S6K1 deficiency leads to
higher EE and a lean phenotype, even when mice are chronically
exposed to a HFD with a 60% lipid content [2]. In contrast, S6K
over-activation in the hypothalamus decreases EE [6]. The
mechanism through which S6K controls energy homeostasis
could involve regulation of lipid metabolism, since ex vivo studies
in muscle, primary hepatocytes and epididymal white adipose
tissue have shown that the combined absence of S6K1 and 2 leads
to changes in AMPK activity, mitochondrial biogenesis and beta
oxidation [7]. However, it remains unclear whether these effects
are retained in vivo or whether the control of systemic energy
metabolism by S6K is regulated by dietary lipids.
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systemic regulation of energy balance by the mTORC1/S6K
pathway, we assessed the role of dietary lipids in determining the
metabolic phenotype of mice lacking S6K 1 and 2. The results of
this study indicate that the metabolic control of energy balance by
S6K is regulated by dietary lipids.
Results
Fatty acids activate S6K1 in vitro independently of
branched-chain amino acids
Earlier experiments in rats suggested that exposure to a HFD
might activate S6K1 in muscle, liver and mediobasal hypothal-
amus [4,5]. We therefore analyzed whether relevant dietary fatty
acids such as oleic acid and palmitoleic acid can directly induce
S6K phosphorylation in vitro. Incubation of muscle Sol 8 cells or
neuronal N-41 cells with oleic acid, palmitoleic acid or linoleic
acid consistently activated S6K1 in a dose- and time-dependent
manner (Fig. 1A–D and Figs. S1A–B, S3).
Since S6K1 has been reported to function in vivo as a nutrient
sensor that responds to branched-chain amino acids such as leucine
[3], we further assessed whether S6K1 activation by fatty acids was
dependent on amino acids. Both oleic acid and palmitoleic acid
induced S6K1 phosphorylation independently of branched-chain
amino acidsor indeedany otheramino acids(Fig. 1Eand Fig. S1C).
The S6K1 phosphorylation induced by these fatty acids was
enhanced by insulin and prevented by rapamycin, as expected for
an effector pathway downstream of mTORC1 (Fig. S1D).
Dietary NEFAs activate skeletal muscle S6K in vivo
Consistent with our in vitro findings, male C57BL/6 mice reared
on a HFD (60% fat content, n=7) for 6 wk showed a significantly
higher level of phosphorylated S6K in muscle (P,0.01) compared
to those that received a FFD (0% fat content, n=7) (Fig. 2A, B) with
no differences in total S6K1 protein levels (Fig. 2C). As expected,
mice fed a HFD (n=8) showed significantly increased bodyweight
(45.7761.85 g, P,0.001) and plasma insulin (2.8160.5 ng/ml,
P,0.001) compared to the FFD control group (30.9861.16 g and
0.7160.08 ng/ml, respectively; n=7) (Fig. 2D, E).
Targeted deletion of S6K protects against HFD-induced
obesity
To uncover the functional relevance of in vivo S6K activation
by dietary lipids, we compared the effect of HFD and standard
Figure 1. Fatty acids activate S6K1 in vitro in the muscle cell line Sol 8. Oleic acid increased S6K1 phosphorylation in Sol 8 cells in a dose-
dependent (A) and time-dependent (B) manner. Similar results were obtained with palmitoleic acid (C and D). S6K1 phosphorylation induced by
palmitoleic acid was independent of branched-chain amino acids and amino acids in general (E). A.A., amino acid; B.C., branched-chain amino acid.
One way ANOVA *P,0.05, **P,0.01, ***P,0.001; two-tailed t test #P,0.05, ##P,0.01.
doi:10.1371/journal.pone.0032631.g001
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significantly lower BW (Fig. 3A, B) and fat mass (Fig. 3C, D) on
both standard chow diet (23.3060.45 g and 3.6360.39 g,
respectively; n=12; P,0.001) and HFD (24.0360.57 g and
2.0460.20 g, respectively; n=9; P,0.001) compared to wt
controls (standard chow, 32.5960.51 g and 6.5160.57 g, respec-
tively; HFD, 37.3961.1 g and 11.7560.67 g, respectively; n=12–
13). S6K-dko mice had persistent lower BW than wt mice despite
having a higher FI on both standard chow and HFD (Fig. S2A,
S2B). Consistent with this observation, EE measured for 48 h and
normalized to lean mass was significantly higher in S6K-dko
(n=12, P,0.01) than wt control mice (n=12) when both were fed
on standard chow (Fig. 3E). This difference in EE was amplified
considerably upon acute exposure (5 d) to a HFD containing 60%
lipids (n=12, P,0.001) (Fig. 3F). The EE levels remained
significantly higher in S6K-dko on a HFD for more than 9 mo
(n=9, P,0.05) when compared to age- and sex-matched wt
controls reared under similar conditions (n=13) (Fig. 3G).
The metabolic phenotype of S6K-dko mice depends on
dietary lipids
To address the role of dietary macronutrients in the control of
energy metabolism by S6K in vivo, we first analyzed EE in S6K-
dko mice that had been fasted for 24 h (indicated with an arrow
in Fig. 3H). EE decreased rapidly in S6K-dko (n=9) to match
that of wt controls (n=13, Fig. 3H). To further analyze whether
the metabolic phenotype of S6K-dko mice was limited to dietary
fatty acids, we compared the impact of chronic exposure to HFD
versus FFD in a new group of age- and sex-matched wt and S6K-
dko mice. Caloric content from protein was kept equal between
both diets (20%). S6K-dko mice fed a HFD for 3 mo (n=6) had
significantly higher EE than wt controls (n=7) when normalized
for BW (P,0.001, Fig. 4B; 24.462.26 kcal/h/kg BW P,0.01,
Fig. 4D), body surface area (P,0.001, Fig 4F; 9.460.9 kcal/h/kg
BW
0.75, P=0.0108, Fig 4H) or lean mass (P,0.05, Fig. 4J;
29.362.34 kcal/h/kg lean mass, P=0.0118, Fig. 4L) compared
to the wt control group (16.1160.9 kcal/h/kg BW,
Figure 2. Dietary fatty acids activate S6K1 in muscle. Mice fed a high-fat diet for 6 wk show significantly higher phosphorylated S6K1 (A, B)
with no changes in total S6K1 protein levels when compared to control mice fed a fat-free diet (C). Body weight (D) and plasma insulin levels (E) were
significantly higher in mice on a high-fat diet. Two tailed t test **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0032631.g002
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0.75, and 22.5660.56 kcal/h/kg lean
mass). In the absence of dietary lipids (S6K-dko and wt mice on
FFD), however, no EE phenotype was detectable (Fig. 4A, C, E,
G, I, K).
Lower fat mass gain and plasma levels of leptin,
cholesterol and triglycerides depend on dietary lipids in
S6K-dko mice
S6K-dko mice fed a HFD for 3 mo had significantly lower fat
mass gain (1.560.4 g, P,0.001, n=7) (Fig. 5B), plasma levels of
leptin (0.7460.05 ng/ml, P,0.01, n=6) (Fig. 5D), cholesterol
(2.7160.31 mg/dl, P,0.01, n=7) (Fig. 5F), and triglycerides
(2.3360.2 mg/dl, P,0.001, n=7) (Fig. 5N), and higher plasma
levels of NEFAs (0.5260.05 nmol/ml, P,0.05, n=7) (Fig. 5J)
compared with age- and sex-matched wt control mice (fat mass
gain, 6.3560.8 g; leptin, 2.0360.30 ng/ml; cholesterol,
6.3660.83 mg/dl; triglycerides, 4.960.49 mg/dl; NEFAs,
0.3760.05 nmol/ml; n=7). There were no significant differences
in plasma adiponectin or resistin levels between S6K-dko mice
(n=6) and wt controls (n=5–7) (Fig. 5H, L).
When the mice were fed a FFD, the only identifiable difference
was lower plasma adiponectin (9776104 pg/ml, P,0.05, n=5)
(Fig. 5G), resistin (12436106 pg/ml, P,0.01, n=5) (Fig. 5K) and
triglycerides (1.7260.1 mg/dl, P,0.01, n=6) (Fig. 5M) in S6K-dko
compared to wt controls (adiponectin, 18976260 pg/ml; resistin,
20136178 pg/ml; triglycerides, 308760.36 mg/dl; n=7).
S6K deficiency protects against HFD-induced glucose
intolerance
S6K-dko mice fed a HFD for 3 mo exhibited greater glucose
tolerance (P,0.001, n=6) (Fig. 6D) and significantly lower fasting
plasma glucose (118.366.8 mg/dl, P,0.001, n=7) (Fig. 6E) and
insulin (0.159960.01 mg/dl, P,0.05, n=5) (Fig. 6F) compared to
wt controls (175.5610.9 mg/dl and 0.416760.11 mg/dl, respec-
tively; n=7). No such differences in glucose tolerance (Fig. 6A) or
fasting plasma glucose (Fig. 6B) were detected when mice were fed
a FFD. However, S6K-dko mice had significantly lower plasma
insulin (0.063360.001 ng/ml, P,0.001, n=5) (Fig. 6C) com-
pared to wt controls (0.116160.007 ng/ml, n=7) when dietary
lipids were absent.
Enhanced muscle fatty acid metabolism in S6K-dko mice
depends on dietary lipids
Muscle tissue from S6K-dko mice fed on a HFD had
significantly higher levels of mRNA for Ucp-3 (P,0.05, n=5)
Figure 3. S6K-dko have higher energy expenditure levels. S6K-dko have significantly lower body weight (A) and fat mass (C) than wt controls
even when fed a high-fat diet (B, D). Energy expenditure corrected by lean mass levels is higher in S6K-dko when fed standard chow (E), acute high-
fat diet (F) or chronic high-fat diet (G) compared to wt controls. Higher energy expenditure in S6K-dko is reduced with 24 h fasting (H). HFD, high-fat
diet. Two-tailed t test ***P,0.001 and two-way ANOVA *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0032631.g003
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(Fig. 7F) and Pdk-4 (P,0.05, n=5) (Fig. 7H) compared to muscle
from wt controls (n=6–7). In the absence of dietary lipids,
however, no such differences were detected (Fig. 7A, C, E, G).
BAT thermogenesis does not regulate the dietary lipid-
dependent metabolic phenotype of S6K-dko mice
BAT from S6K-dko mice (n=6) fed a HFD for 5 mo had lower
Ucp-1 mRNA levels (n=5, P,0.05) (Fig. 8B) and higher
sympathetic activity (n=6, P,0.01) (Fig. 8D, F) compared with
BAT from wt controls (n=7). Therefore, it is unlikely that
differences in BAT uncoupling explain the observed energy
metabolism phenotype. On a FFD, no significant differences in
Ucp-1 mRNA levels were detected in BAT from S6K-dko mice
(n=5) (Fig. 8A), compared to wt controls (n=6–7). BAT
sympathetic activity in mice fed a FFD (n=5, P,0.001) was still
higher in the S6K-dko mice than wt controls (Fig. 8C, E).
Discussion
The results of this study show that S6Ks are directly activated
by fatty acids in vitro and in vivo, a finding that appears to expand
the role of S6K as a nutrient sensor. More importantly, our data
suggest that the predominant role of S6K in metabolic regulation
is in the response to dietary lipids.
Previously, it has been demonstrated that exposure to a HFD
leads to the activation of S6K1 in muscle and liver tissue [4] and
also in the hypothalamus [5]. Phosphorylation of S6 (a signaling
protein downstream of mTORC1 and S6K1 and 2) has also been
observed in the hypothalamus of fed ob/ob and db/db mice [8], a
finding that is consistent with leptin-independent, nutrient-
activated regulation of this pathway. Based on these studies, and
our own in vitro and in vivo observations indicating that fatty acids
can directly activate S6K1, we hypothesized that the metabolic
phenotype of S6K1 and 2 deficient mice is at least partly
dependent on exposure to dietary lipids.
When S6K-dko mice were fed a HFD for an extended period,
they gained less body fat and exhibited a marked increase in EE
compared with wt mice and S6K-dko mice fed on a FFD. S6K-
dko mice also had lower fasting leptin levels, lower cholesterol,
higher NEFAs and better glucose tolerance on a HFD compared
to wt mice. However, none of these features occurred in the
absence of dietary lipids. Under these conditions, all mice had
normal FI, BW and good health, and long-term FFD exposure did
not appear to have any non-specific or adverse effects. Since the
metabolic phenotype of S6K-dko mice—involving changes in
adiposity, energy metabolism, and glucose tolerance—fails to
develop when the mice are fed on a FFD, we conclude that
metabolic control by S6K is predominately regulated by dietary
lipids.
Hypothalamic S6K over-activation in rats decreases EE [6],
whereas S6K1-ko and adipose tissue-specific raptor ko mice show
higher EE levels [2,9,10]. Consistent with the results of those
studies, S6K-dko mice show high EE. Defining the specific tissue
responsible for the considerable EE phenotype is of great interest.
Our results indicate that BAT is unlikely to be the only cause of
the significantly higher EE levels in response to lipids, since Ucp-1
mRNA expression in S6K-dko mice fed a HFD was lower despite
higher BAT sympathetic activity. In fact, adipose tissue has been
proposed as a source of higher levels of EE in mice with specific
Figure 4. Energy expenditure levels in S6K-dko are diet regulated. Energy expenditure normalized for body weight (B, D), body surface area
(F, H) or lean mass (J, L) is higher in S6K-dko than wt mice when fed a high-fat diet. No differences in energy expenditure are observed between S6K-
dko and wt control mice fed a fat-free diet (A, C, E, G, I, K). BW, body weight; EE, energy expenditure; FFD, fat-free diet; HFD, high-fat diet. Two-tailed t
test *P,0.05, **P,0.01 and two-way ANOVA *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0032631.g004
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32631Figure 5. S6K-dko plasma biochemistry. S6K-dko mice fed a high-fat diet show significantly lower fat mass gain (B), plasma leptin (D),
cholesterol (F) and triglycerides (N), as well as higher free fatty acids (J) compared to wt controls. When fed a fat-free diet, S6K-dko mice still show
significantly lower plasma triglycerides (N), as well as significantly lower adiponectin (H) and resistin (K) levels. FFD, fat-free diet; HFD, high-fat diet;
NEFAs, non-esterified fatty acids. Two-tailed t test *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0032631.g005
Figure 6. S6K-dko glucose tolerance and diet. S6K-dko mice fed a high-fat diet have significantly higher glucose tolerance (D) and lower plasma
glucose (E) and insulin (F) compared to wt controls. When fed a fat-free diet, S6K-dko mice do not show better glucose tolerance (A) or lower plasma
glucose levels (B) in spite of having significantly lower plasma insulin levels (C). FFD, fat-free diet; HFD, high-fat diet. One-tailed t test *P,0.05, two-
tailed t test ***P,0.001 and two-way ANOVA ***P,0.001.
doi:10.1371/journal.pone.0032631.g006
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32631Figure 7. Muscle lipid beta oxidation in S6K-dko is diet regulated. S6K-dko mice fed a high-fat diet have higher muscle lipid beta oxidation,
as shown by significantly higher mRNA levels of Ucp-3 (B), Cpt-1b (D), Acca (F) and Pdk-4 (H). No such differences were observed in mice fed a fat free
diet (A, C, E, G). FFD, fat-free diet; HFD, high-fat diet. Two-tailed t test *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0032631.g007
Figure 8. Brown adipose tissue thermogenesis in S6K-dko is diet independent. S6K-dko mice fed a high-fat diet have significantly lower
levels of Ucp-1 mRNA in brown adipose tissue (B) and higher sympathetic activity (D, F) compared to wt controls. When fed a fat-free diet, S6K-dko
mice show no significant differences in Ucp-1 mRNA levels in brown adipose tissue (A) but do have significantly higher sympathetic activity (C, E)
compared to wt controls. BAT, brown adipose tissue; FFD, fat-free diet; HFD, high-fat diet. Two-tailed t test **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0032631.g008
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expression of uncoupling proteins was similar to or lower than in
controls in that study. On the other hand, we found that the
expression of genes linked to energy metabolism, including Ucp-3,
Cpt-1b, Acca and Pdk-4, was up-regulated in skeletal muscle when
S6K-dko mice were fed a HFD. This suggests that skeletal muscle
thermogenesis is a more likely cause of the substantial EE response
to dietary lipids. This finding is consistent with recently published
data in which the absence of S6K or treatment with rapamycin
promoted fatty acid oxidation in muscle cells [7,11]. Interestingly,
mice lacking raptor in skeletal muscle die early and show muscle
dystrophy, lower muscle mitochondrial biogenesis and reduced
oxidative capacity [12].
The physiological events associated with the absence of S6K
resemble those seen with caloric deprivation, in which insulin
levels are low and gluconeogenesis is augmented. In both
situations, lipids are used as the main source of energy in order
to preserve glucose for the central nervous system and erythrocytes
[13,14]. The significantly higher fasting NEFAs and lower plasma
triglyceride levels observed in S6K-dko fed a HFD could suggest a
higher sensitivity and more efficient response to the perceived lack
of dietary lipids. Consistent with this possibility, rapamycin
administration in human lymphoma cells alters gene expression
in a manner similar to that observed upon starvation [15] and
decreased mTOR signaling has been linked to starvation-induced
stress, higher mitochondrial respiration and extended life-span in
yeast [16,17,18]. In mammals, mTOR signaling has also been
linked to longevity [19]. Specifically, levels of phosphorylated
S6K1 were reduced in muscle and liver in a mouse model of
extended life span [20]. However, it remains possible that the
physiological differences observed in our study are also a
consequence of altered sensing of dietary sugars, as the HFD
and FFD used differed in carbohydrate content, and skeletal
muscle energy metabolism depends heavily on insulin-stimulated
glucose uptake [21].
We found that S6K activation by fatty acids in vitro depends on
mTORC1 but not on amino acids. However, the mechanisms
underlying this observation remain unclear. mTORC1 transloca-
tion to lysosomal membranes and subsequent activation in vitro
occurs in response to amino acids [22,23]. However, it is not clear
how NEFAs influence this pathway in similar cell models (human
embryonic kidney cells and mouse embryonic fibroblasts). Further
studies will therefore be required to elucidate the mechanisms
underlying fatty acid-dependent, amino acid-independent
mTORC1/S6K activation and function.
Since exposure to dietary fatty acids may directly affect nutrient
sensing neurons expressing S6K in the arcuate nucleus in vivo [3],
the mediobasal hypothalamus could represent an important site at
which the action of S6K links dietary lipids to the control of
adaptive thermogenesis. According to such a model, S6K in the
arcuate nucleus could be involved in the regulation of skeletal
muscle metabolism by the central nervous system. However,
tissue-specific gene targeting will be necessary to address whether
these differences in energy metabolism in response to dietary lipids
are a direct consequence of the lack of S6K activation in skeletal
muscle, an indirect effect of S6K modulation in the central
nervous system influencing muscle EE via efferent SNS activity, or
a combination of the two.
An intriguing effect of null mutations for both S6Ks is the
protection against lipotoxicity [24], presumably as a collateral
effect of the enhanced muscle fatty acid beta oxidation in mice fed
a HFD. Since the mTORC1 pathway mediates cell proliferation
[25], as reflected by the smaller size of the S6K-dko mice [26], and
lack of S6K1 impairs adipogenesis [27], lipid deposition outside of
adipose tissue might be expected in response to chronic HFD
exposure. However, higher lipid oxidation in skeletal muscle
apparently provides protection against such adverse effects and
thereby prevents the detrimental metabolic consequences of
limited adipose tissue expansion capabilities in the absence of
S6K. This suggests that the absence of S6K not only protects
against obesity but also against potential lipotoxicity as a result of
collateral hypotrophy.
In summary, we conclude that S6K deficiency in the absence of
dietary lipids has no physiologically relevant metabolic conse-
quences even when animals are chronically exposed to consider-
able amounts of dietary carbohydrates (Fig. 9). Our findings are
consistent with a role for S6K activity in the development of
dietary fatty acid-induced metabolic disease. Finally, our results
show that S6K deficiency specifically protects against the
pathological effects of dietary lipids and suggest that the S6K
pathway in skeletal muscle may represent a valuable molecular
target for the treatment of metabolic diseases. Further studies will
be necessary to elucidate the role of S6Ks in skeletal muscle and
central nervous system as a putative molecular interface between
dietary lipids and the endogenous control of systemic energy and
glucose and lipid metabolism.
Materials and Methods
Animals
Mice lacking S6K1 and S6K2 (S6K-dko) were generated as
described by Pende at al. [26]. Age- and sex-matched S6K1-ko
mice were originally generated in a mixed 129/SveJ6C57Bl/6
line and the S6K2-ko mice in a mixed 129/OlaHSD6C57Bl/6
line [26,28]. Male S6K-dko and wild-type (wt) mice were housed
in individual cages under a 12:12 h light-dark cycle (7 am light on)
Figure 9. Model of metabolism regulation by diet in absence of S6K. Mice S6K-dko show lower fat mass gain and higher glucose tolerance,
energy expenditure and muscle lipid b-oxidation compared with wt mice when consuming a high fat diet. Those metabolic differences are not
present in absence of dietary lipids.
doi:10.1371/journal.pone.0032631.g009
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Teklad Laboratory Diets, Wisconsin, USA), fat-free diet (FFD)
(0% kcal from fat, D04112303 Research Diets Inc., New Jersey,
USA) or HFD (60% kcal from fat [D12492] and 45% kcal from fat
[D12451], Research Diets Inc., New Jersey, USA) and tap water.
All animal protocols were approved by the University of
Cincinnati Institutional Animal Care and Use Committee. For
the first round of experiments, mice received standard chow or
60% kcal HFD for 9 mo after weaning; for the second round of
experiments, mice were placed on FFD or 45% HFD at 2 mo and
continued to receive that diet for 3–5 mo.
Energy balance measurements
Mice were placed in a customized indirect calorimetry system
(TSE Systems GmbH, Bad Homburg, Germany) and FI and EE
were monitored simultaneously for 2–3 d after adaptation. FI
measurements were taken every 30 min and EE measurements
were taken every 45 min at al flow rate of 0.5 l/min. Body
composition measurements were taken using nuclear magnetic
resonance (Whole Body Composition Analyzer; Echo MRI,
Texas, USA).
Glucose tolerance test
Analysis of glucose tolerance was carried out in mice fasted
overnight and injected intraperitoneally with 2 g glucose per kg
body weight (BW) (50% wt/vol D-glucose [Sigma, St Louis, MO,
USA] in 0.9% wt/vol NaCl). Tail-blood glucose levels (mg/dl)
were measured with a glucometer (TheraSense Freestyle) and
standard glucose strips (Free Style; Abbott Laboratories) before
(0 min) and at 15, 30, 45, 60 and 120 min after injection.
Plasma analysis
Mice were killed by decapitation at the end of the study and
blood was collected and immediately chilled on ice. Plasma was
obtained by centrifugation at 3000 g and 4uC for 15 min and then
stored at 280uC. Non-esterified fatty acid (NEFA) levels were
measured using a commercially available enzymatic assay kit
(Autokit NEFA C, Wako, Neuss, Germany). Plasma cholesterol
and triglycerides were determined using Infinity Cholesterol
reagent and Infinity Triglyceride reagent b (Thermo Electron,
Pittsburgh, Pennsylvania, USA). Plasma glucose was measured
using a commercial kit based on the glucose oxidase method
(Biomerieux, Marcy l’Etoile, France). Plasma insulin and leptin
were measured using a mouse radio-immunoassay (Linco
Research, St Charles, MO, USA). The intra- and inter-assay
coefficient of variation was 2.7–5.8% and 3.8–10.8%, respectively,
for insulin and 4.0–11.2% and 3.3–14.6%, respectively, for
leptin. Plasma adiponectin and resistin were measured with a
Luminex100 TM IS analyzer (Luminex Corporation, Austin, TX,
USA) and mouse lincoplex kits (Linco Research, St Charles, MO,
USA). The intra- and inter-assay coefficient of variation was ,5%
and ,12%, respectively, for adiponectin and ,4.5% and
,10.3%, respectively, for resistin. All assays were performed
according to the manufacturer’s instructions.
Real-time quantitative PCR
S6K-dko and wt mice were killed following sympathetic nervous
system (SNS) recordings performed after approximately 5 mo of
exposure to FFD and HFD. Brown adipose tissue (BAT) and
gastrocnemius muscle were collected and stored at 280uC prior to
analysis of mRNA expression for uncoupling protein 3 (Ucp-3),
carnitinepalmitoyl-transferase 1 beta (Cpt-1ß), acetyl coenzyme A
carboxylase (Acc) alpha and pyruvate dehydrogenase kinase 4 (Pdk-
4) by real-time quantitative PCR (qPCR) in an iCycler Optical
Module (BioRad Hercules, CA, USA) (Table 1). Total RNA was
extracted from frozen tissue samples using the RNeasy Lipid Mini
Kit (Qiagen, Valencia, CA, USA). cDNA templates for qPCR
were synthesized using 0.5 mg of total RNA, 106DNase reaction
buffer, DNase 1 amp grade, dNTPs, random primers, and
Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA,
USA). qPCR was performed using iQ SYBR Green Supermix
(BioRad, Hercules, CA, USA) according to the standard protocol
with approximately 70 ng template cDNA. All primers were used
at a final concentration of 0.5 mM. A standard curve was used to
obtain the relative concentration of each experimental gene; values
were normalized to the concentration of the housekeeping gene
hypoxanthine–guanine phosphoribosyltransferase (Hprt) in each
sample.
Cell culture and Western blot analysis
The mouse muscle cell line Sol 8 was a generous gift from Dr.
Silvana Obici (University of Cincinnati) and the hypothalamic cell
line N-41 was obtained from Cellutions Biosystems Inc. (Toronto,
Ontario, Canada). Sol 8 and N-41 cells were grown and
maintained in high-glucose Dulbecco’s Modified Eagle’s Medium
(DMEM) (Hyclone Laboratories, Logan, UT, USA) containing
20% and 10% fetal bovine serum (FBS) (GIBCO Laboratories,
Grand Island, NY, USA), respectively, with antibiotic/antimycotic
mix (GIBCO Laboratories, Grand Island, NY, USA) at 37uCi na
5% CO2 atmosphere. Differentiation of Sol 8 cells was achieved
by seeding the cells in 12-well plates and growing them to 50%
confluence before switching the medium to DMEM containing
5% horse serum (Sigma, St Louis, MO, USA) for 3 d. For
experiments, Sol 8 and N-41 cells were washed with PBS and
incubated in serum-free low-glucose DMEM for 24 h prior to and
during experiments. Serum-starved cells were then treated for the
Table 1. Primer sequences for RT-PCR.
Mouse
gene Accession # Forward sequence Reverse sequence Product Annealing T
Ucp-1 NM_009463 59GGGCCCTTGTAAACAACAAA39 59GTCGGTCCTTCCTTGGTGTA39 196 60
Ucp-3 NM_009464 59GTCTGCCTCATCAGGGTGTT39 59CCTGGTCCTTACCATGCAGT39 204 60
Cpt-1b NM_009948 59CAGCGCTTTGGGAACCACAT39 59CACTGCCTCAAGAGCTGTTCTC39 203 60
Acc-a NM_133360 59-GCCTCTTCC TGACAAACGAG-39 59-TGACTGCCG AAACATCTCTG-39 239 60
Pdk4 NM_013743 59CCTTTGGCTGGTTTTGGTTA39 59CCTGCTTGGGATACACCAGT39 294 60
Hprt NM_013556 59TGCTCGAGATGTCATGAAGG39 59TATGTCCCCCGTTGACTGAT39 196 60
doi:10.1371/journal.pone.0032631.t001
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preincubated with 0.1% fatty acid-free BSA overnight at 4uC
(Sigma, St Louis, MO, USA). Following the different treatments,
the cells were lysed in ice-cold RIPA buffer containing protease
inhibitors (16PBS, 1% Nonidet P40, 0.5% sodium deoxycholate,
0.1% SDS with 50 mM NaF, 0.5 M phenylmethylsulfonyl
fluoride, 0.1 mM sodium vanadate, aprotinin [10 mg/ml], and
leupeptin [5 mg/ml]) (Sigma, St Louis, MO, USA). N-41 cells were
also incubated with or without insulin and the mTOR inhibitor
rapamycin (20 nM) (Sigma, St Louis, MO, USA). Following the
different treatments, the cells were lysed in ice cold RIPA buffer
containing protease inhibitors. Lysates were collected in a 1.5-ml
tube and cleared by centrifugation at 4uC for 10 min at 7500 rpm.
An aliquot of sample was used for determination of protein
concentration. Samples were then boiled in 46 lithium dodecyl
sulfate/dithiothreitol buffer (Invitrogen, Carlsbad, CA, USA;
American Bioanalytical, Natick, MA, USA) for 10 min at 70uC.
Cell lysates (50 mg protein) were loaded on 9% (w/v) acrylamide
resolving gels, separated by SDS-PAGE and transferred to
Hybond ECL nitrocellulose membranes (Amersham Biosciences,
Piscataway, NJ, USA). Membranes were blocked in 2% ECL
advance blocking agent for 1 h at room temperature and probed
with primary antibodies for S6K (Cell Signaling, Beverly, MA,
USA) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). After
washing, primary antibodies were detected using either HRP-
conjugated anti-mouse IgG for phosphorylated-S6K (Thr389) or
anti-rabbit IgG for GAPDH (Bio-Rad, Hercules, CA, USA).
Protein bands were visualized using advance chemiluminescence
(Amersham Biosciences, Piscataway, NJ, USA), exposed to CL-
Xposure film (Pierce, Rockford, IL, USA) and then quantified
using AlphaEase FC software.
To measure S6K activation independently of NEFA, Sol 8 and
N-41 cells were treated as described above. After 24 h incubation
in serum-free medium, cells were washed in PBS and incubated for
2 h in amino acid-free DMEM basic medium. Cells were then
treated with BSA-conjugated palmitoleic acid (200 mM) for 1 h in
either amino acid-free, branched-chain amino acid-free or
branched-chain amino acid-supplemented DMEM. Cells were
lysed and treated as previously described.
For quantification of S6K in the soleus muscle of male C57BL/
6 mice, both soleus muscles were collected from animals reared on
FFD and 60% HFD and euthanized after 6 wk. Tissues were
immediately placed in RIPA buffer containing protease inhibitors,
and then samples were lysed with a TissueLyser (Qiagen,
Valencia, CA, USA) for 3 min and centrifuged at 4uC for
10 min at 7500 rpm. Supernatant was transferred to a new tube
and an aliquot was taken for protein quantification. Phosphory-
lated-S6K1 (Thr389) and total S6K1 were quantified using the
protocol described above.
Sympathetic nervous system recordings
Each mouse was initially anesthetized by intraperitoneal
injection with a ketamine/xylazine cocktail (91 mg/kg ketamine
and 9.1 mg/kg xylazine). A PE-50 tube was inserted into the
trachea for unobstructed spontaneous breathing and a catheter
was inserted into the right jugular vein to maintain anesthesia with
alpha-chloralose (25 mg/kg initially, followed by 6 mg/kg/h
during the protocol). To monitor blood pressure and heart rate,
a catheter was inserted into the left carotid artery. Rectal body
temperature was maintained at 37.5uC using a lamp and heating
pad. A nerve innervating BAT was isolated and placed on bipolar
platinum-iridium electrodes for recordings. The nerve signal was
amplified 100,0006 at high-frequency and low-frequency cutoffs
of 1 kHz and 100 Hz, respectively. Blood pressure, heart rate and
BAT sympathetic nerve activity were recorded continuously for
the next 20–30 min. At the end of the recording session, the nerve
was broken and the background noise was measured and
subtracted from baseline activity of the BAT SNS.
Statistical analysis
Quantitative data are presented as mean 6 standard error of
the mean (SEM). Data were compared by one-way and two-way
repeated measures analysis of variance (ANOVA) with post-hoc
Bonferroni and Dunnett tests and by one- or two-tailed, unpaired t
tests. P,0.05 was considered statistically significant (GraphPad
Prism software).
Supporting Information
Figure S1 Fatty acids activate S6K1 in vitro in the
hypothalamic cell line N-41. Palmitoleic acid increases S6K1
phosphorylation in N-41 cells in a dose-dependent (A) and time-
dependent (B) manner. Palmitoleic acid-induced phosphorylation
was independent of branched-chain amino acids and amino acids
in general (C). S6K1 phosphorylation induced by palmitoleic acid
was enhanced by insulin and prevented by rapamycin, suggesting
a mechanism involving the mTORC1 pathway (D). A.A., amino
acid; B.C., branched-chain amino acid. One way ANOVA
*P,0.05, **P,0.01, ***P,0.001; two-tailed t test #P,0.05.
(TIF)
Figure S2 S6K-dko and food intake. In spite of their lean
phenotype, S6K-dko show higher food intake on standard chow
(A) or a high-fat diet (B). BW, body weight; HFD, high-fat diet.
Two-way ANOVA *P,0.05, **P,0.01.
(TIF)
Figure S3 Fatty acids activate S6K1 in vitro in the
muscle cell line Sol8. Linoleic acid increases S6K1 phosphor-
ylation in Sol8 cells in a dose-dependent manner. One way
ANOVA **P,0.01.
(TIF)
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